Primary pulmonary lymphoma from bronchus-associated lymphoid tissue (clinical observation)

Authors

  • I. V. Zhulkevych I. Нorbachevsky Ternopil State Medical University, Ukraine,
  • I. Yo. Halaichuk I. Нorbachevsky Ternopil State Medical University, Ukraine,

DOI:

https://doi.org/10.14739/2310-1237.2019.2.177201

Keywords:

Key words, lymphoma, lung neoplasms, diagnosis, treatment

Abstract

 

Purpose. To describe the clinical case of rare indolent extranodal non-Hodgkin’s lymphoma, which originates from bronchus-associated lymphoid tissue, and to analyze the main current trends in the diagnosis and treatment of this pathology.

Using bibliosemantic and analytical methods of research in modern scientific literature, we analyzed the main historical data and clinical-radiological and immunomorphological criteria for the diagnosis of casuistically rare neoplasm – the primary pulmonary non-Hodgkin's lymphoma – the indolent extranodal B-cell lymphoma of the marginal zone, arising from the bronchus-associated lymphoid tissue (BALT). The prevalence of BALT-lymphoma is less than 0.5 % of all pulmonary malignant tumors and less than 1 % of all non-Hodgkin’s lymphomas. Nowadays, diagnostic approaches and standard systemic treatment of this disease are still widely discussed. The recommendations of the retrospective international study of primary extranodal lymphoma of lungs from the marginal zone conducted by the international extranodal lymphoma study group (IELSG) are presented and the main recommendations of the NCCN for the diagnosis and treatment of mucosa-associated lymphoma (2019) are analyzed. Treatment options for BALT-lymphomas vary in the range from antibiotic therapy and clinical observation to surgical resection or combination with chemotherapy and radiotherapy, but optimal therapy for the disease needs further study. It is noted that precise morphological definition and immunohistochemical phenotyping allow choosing an adequate protocol for chemo-therapeutic treatment (immunochemotherapy). The main options for radical surgical, chemo-therapeutic and radiological stages of BALT-lymphoma treatment and indications for their combined use within the framework of the multidisciplinary approach to treatment with lymphomas are discussed and their effectiveness is determined. The actual 4-year clinical observation of 48 year old patient with BALT-lymphoma is presented and the main radiological diagnostic criteria and difficulties of morphological diagnostics and immunohistochemical phenotyping are discussed. The above clinical observation is aimed at information of a wide range of practicing doctors – therapists, pulmonologists, phthisiologists, thoracic surgeons, oncologists, radiologists.

Conclusions. BALT-lymphoma is a rare form of extranodal non-Hodgkin’s lymphoma, that does not have clear clinical guidelines and specific radiological signs and requires well-balanced histological diagnostics and immunohistochemical verification, which, in combination with computed tomography (PET-CT) methods, determines the stage of the disease and, respectively, tactics for the management of patients.

References

Eloranta, S., Branvall, E., Celsing, F., Papworth, K., Ljungqvist, M., Enblad G., et al. (2018). Increasing incidence of primary central nervous system lymphoma but no improvement in survival in Sweden 2000–2013. 100(1), 61–68. doi: 10.1111/ejh.12980

Shevchenko, A. I., Sidorenko, А. M., & Krohmalnaya, E. R. (2014). Epidemiolohiia nekhodzhkinskykh limfom v XX i na pochatku XXI stolittia [Epidemiology of Non-Hodgkin Lymphomas in the 20th and at the beginning of the 21st century]. Pathologia, 3(32), 4–9. [in Ukrainian]. doi: https://doi.org/10.14739/2310-1237.2014.3.36544

Nahorecki, A., Chrabovski, M., Straszak, E., Teplicki, A., Szuba, A., Langfort, R., & Janchak, D. (2016). Primary pulmonary MALT lymphoma – case report and literature overview. Eur Rev Med Pharmacol Sci., 20(10), 2065–2069.

Tiruneh, F., Awan, A., Amin, R., Afreen, S., Musa, A., & Davis, W. (2017). A Rare Case of Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma Transforming into Diffuse Large B-Cell Lymphoma. Cureus, 9(6), e1373. doi: 10.7759/cureus.1373

Isaacson, P., Al-Dewachi, H. S. & Mason, D. Y. (1983). Middle Eastern interstinal lymphoma: a morphological and immunohistochemical study. J. Clin. Pathol., 36(5), 489–498. doi: 10.1136/jcp.36.5.489

Isaacson, P., & Wright, D. H. (1983). Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma. Cancer, 52(8), 1410–1416. doi: 10.1002/1097-0142(19831015)52:8<1410::aid-cncr2820520813>3.0.co;2-3

Zucca, E., & Bertoni, F. (2016). The spectrum of MALT lymphoma at different sites: biological and therapeutic relevance. Blood, 127(17), 2082–2092. doi: 10.1182/blood-2015-12-624304

Swerdlow, S. H., Campo, E., Pileri, S. A., Harris, N. L., Stein, H., Siebert, R., et al. (2016). The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood, 127(20), 2375–90. doi: 10.1182/blood-2016-01-643569

Maeshima, A. M., Taniguchi, H., Toyoda, K., Yamauchi, N., Makita, S., Fukuhara, S., et al. Clinicopathological features of histological transformation from extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue to diffuse large B-cell lymphoma: an analysis of 467 patients. (2016). British Journal of Haematology, 174(6), 923–931. doi: 10.1111/bjh.14153

Borie, R., Antoine, M., Cadranel, J., & Wislez, M. (2014). Pulmonary malt lymphoma. Bull Cancer, 101(2), 195–202. doi: 10.1684/bdc.2014.1885

Albano, D., Borghesi, A., Bosio, G., Bertoli, M., Maroldi, R., Giubbini, R., & Bertagna, F. (2017). Pulmonary mucosa-associated lymphoid tissue lymphoma: 18F-FDG PET/CT and CT findings in 28 patients. Br J Radiol, 90(1079), 20170311. doi: 10. 1259/bjr. 20170311

Natsionalnyi kantser-reiestr Ukrainy. Retrieved from: http://www.ncru.inf.ua/publications/index.htm.http://www.ncru.inf.ua/publications/index.htm

Sirajuddin, A., Raparia, K., Lewis, V. A., Franks, T. J., Dhand, S., Galvin, J. R., & White, C. S. (2016). Primary Pulmonary Lymphoid Lesions: Radiologic and Pathologic Findings. Radiographics, 36(1), 53–70. doi: 10.1148/rg.2016140339

Borie, R., Wislez, M., Antoine, M., & Cadranel, J. (2017). Lymphoproliferative Disorders of the Lung. Respiration, 94(2), 157–175. doi: 10.1159/000477740

Bligh, M. P., Borgaonkar, J. N., Burrell, S. C., MacDonald, D. A., & Manos, D. (2017). Spectrum of CT Findings in Thoracic Extranodal Non-Hodgkin Lymphoma. Radiographics, 37(2), 439–461. doi: 10.1148/rg.2017160077

Iftikhar, A., Magh, A., Cheema, M. A., Thappa, S., Sahni, S., & Karbowitz, S. (2017). Primary pulmonary MALT lymphoma presenting as non-resolving pneumonia. Advances in Respiratory Medicine, 85(4), 202–205. doi: 10.5603/ARM.2017.0033

Barrington, S. F., Mikhaeel, N. G., Kostakoglu, L., Meignan, M., Hutchings, M., Mueller, S. P., et al. (2014). Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol, 32(27), 3048–3058. doi: 10.1200/JCO.2013.53.5229

Ibrahim, U., Saqib, A., Pant, M., Garcia, G., & Odaimi, M. (2018). Synchronous Pulmonary Neoplasms: A Chance Occurrence or is There More Than Meets the Eye? Cureus, 10(2), e2162. doi: 10.7759/cureus.2162

Hiraishi, Y., Iikura, M., Kogure, Y., Hirashima, J., Izumi, S., & Sugiyama, H. (2014). Two tracheal BALT lymphoma patients successfully treated with chemotherapy including rituximab. Respiratory Investigation, 52(2), 144–146. doi: 10.1016/j.resinv.2013.07.006

Sammassimo, S., Pruneri, G., Andreola, G., Montoro, J., Steffanoni, S., Nowakowski, G. S., et al. (2016). A retrospective international study on primary extranodal marginal zone lymphoma of the lung (BALT lymphoma) on behalf of International Extranodal Lymphoma Study Group (IELSG). Hematological Oncology, 34(4), 177–183. doi: 10.1002/hon.2243

Zheng, W., Jing, L., Zhixiang, C., Ling, Y., & Peng, L. (2017). A single center experience: rituximab plus cladribine is an effective and safe first-line therapy for unresectable bronchialassociated lymphoid tissue lymphoma. J. Thorac. Dis., 9(4), 1081–1092. doi: 10.21037/jtd.2017.03.81

Downloads

How to Cite

1.
Zhulkevych IV, Halaichuk IY. Primary pulmonary lymphoma from bronchus-associated lymphoid tissue (clinical observation). Pathologia [Internet]. 2019Sep.2 [cited 2024Apr.20];(2). Available from: http://pat.zsmu.edu.ua/article/view/177201

Issue

No. 2 (2019)

Section

Case Reports

License

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Лицензия Creative Commons
    1. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

  1. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).